symbol,statement_type,period_end,line_item,value
BIOCON.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,233858793.596947
BIOCON.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.242341
BIOCON.NS,income,2025-03-31 00:00:00,Normalized EBITDA,43745000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Total Unusual Items,965000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,965000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,10133000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,16870000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,51975000000.0
BIOCON.NS,income,2025-03-31 00:00:00,EBITDA,44710000000.0
BIOCON.NS,income,2025-03-31 00:00:00,EBIT,27840000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Net Interest Income,-8974000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Interest Expense,8974000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Interest Income,
BIOCON.NS,income,2025-03-31 00:00:00,Normalized Income,9401858793.596947
BIOCON.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,10133000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Total Expenses,137205000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
BIOCON.NS,income,2025-03-31 00:00:00,Diluted Average Shares,1197754137.0
BIOCON.NS,income,2025-03-31 00:00:00,Basic Average Shares,1197754137.0
BIOCON.NS,income,2025-03-31 00:00:00,Diluted EPS,8.46
BIOCON.NS,income,2025-03-31 00:00:00,Basic EPS,8.46
BIOCON.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,10133000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,10133000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
BIOCON.NS,income,2025-03-31 00:00:00,Net Income,10133000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Minority Interests,-4161000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,14294000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Net Income Discontinuous Operations,
BIOCON.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,14294000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Tax Provision,4572000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Pretax Income,18866000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,13558000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Special Income Charges,965000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Other Special Charges,-965000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Write Off,
BIOCON.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-8974000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,8974000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
BIOCON.NS,income,2025-03-31 00:00:00,Operating Income,13317000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Operating Expense,85230000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Other Operating Expenses,39011000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,16870000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Amortization,
BIOCON.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,16870000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Research And Development,
BIOCON.NS,income,2025-03-31 00:00:00,Selling General And Administration,
BIOCON.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
BIOCON.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
BIOCON.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
BIOCON.NS,income,2025-03-31 00:00:00,Gross Profit,98547000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Cost Of Revenue,51975000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Total Revenue,150522000000.0
BIOCON.NS,income,2025-03-31 00:00:00,Operating Revenue,150522000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,-17295043.273013
BIOCON.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.149095
BIOCON.NS,income,2024-03-31 00:00:00,Normalized EBITDA,40800000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Total Unusual Items,-116000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-116000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,10225000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,15688000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,48979000000.0
BIOCON.NS,income,2024-03-31 00:00:00,EBITDA,40684000000.0
BIOCON.NS,income,2024-03-31 00:00:00,EBIT,24996000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Net Interest Income,-9744000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Interest Expense,9744000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Interest Income,1613000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Normalized Income,10323704956.726988
BIOCON.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,10225000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Total Expenses,125497000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,3000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Diluted Average Shares,1197306792.0
BIOCON.NS,income,2024-03-31 00:00:00,Basic Average Shares,1195906433.0
BIOCON.NS,income,2024-03-31 00:00:00,Diluted EPS,8.54
BIOCON.NS,income,2024-03-31 00:00:00,Basic EPS,8.55
BIOCON.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,10225000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,10225000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
BIOCON.NS,income,2024-03-31 00:00:00,Net Income,10225000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Minority Interests,-2753000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,12978000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Net Income Discontinuous Operations,
BIOCON.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,12978000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Tax Provision,2274000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Pretax Income,15252000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,9493000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Special Income Charges,-116000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Other Special Charges,116000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Write Off,11000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-9744000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,9744000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,1613000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Operating Income,16461000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Operating Expense,76518000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Other Operating Expenses,39788000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,15688000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Amortization,6295000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,15688000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Research And Development,7961000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Selling General And Administration,8860000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,2966000000.0
BIOCON.NS,income,2024-03-31 00:00:00,General And Administrative Expense,5894000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,3000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Gross Profit,92979000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Cost Of Revenue,48979000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Total Revenue,141958000000.0
BIOCON.NS,income,2024-03-31 00:00:00,Operating Revenue,141958000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,-149700000.0
BIOCON.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.15
BIOCON.NS,income,2023-03-31 00:00:00,Normalized EBITDA,25290000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Total Unusual Items,-998000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-998000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,4627000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,11131000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,36668000000.0
BIOCON.NS,income,2023-03-31 00:00:00,EBITDA,24292000000.0
BIOCON.NS,income,2023-03-31 00:00:00,EBIT,13161000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Net Interest Income,-3066000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Interest Expense,4190000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Interest Income,1124000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Normalized Income,5475300000.0
BIOCON.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,4627000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Total Expenses,96992000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,29000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Diluted Average Shares,1195925590.0
BIOCON.NS,income,2023-03-31 00:00:00,Basic Average Shares,1193095945.0
BIOCON.NS,income,2023-03-31 00:00:00,Diluted EPS,3.87
BIOCON.NS,income,2023-03-31 00:00:00,Basic EPS,3.88
BIOCON.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,4627000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,4627000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
BIOCON.NS,income,2023-03-31 00:00:00,Net Income,4627000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Minority Interests,-1803000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,6430000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Net Income Discontinuous Operations,
BIOCON.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,6430000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Tax Provision,2541000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Pretax Income,8971000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,3961000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Special Income Charges,-806000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Other Special Charges,796000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Write Off,10000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-3066000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,4190000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,1124000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Operating Income,12349000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Operating Expense,60324000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Other Operating Expenses,15917000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,11131000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Amortization,2914000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,8217000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Research And Development,8820000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Selling General And Administration,4867000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,2216000000.0
BIOCON.NS,income,2023-03-31 00:00:00,General And Administrative Expense,2651000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,29000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Gross Profit,72673000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Cost Of Revenue,36668000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Total Revenue,109341000000.0
BIOCON.NS,income,2023-03-31 00:00:00,Operating Revenue,109341000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,-219120000.0
BIOCON.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.22
BIOCON.NS,income,2022-03-31 00:00:00,Normalized EBITDA,19645000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Total Unusual Items,-996000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-996000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,6484000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,8142000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,27236000000.0
BIOCON.NS,income,2022-03-31 00:00:00,EBITDA,18649000000.0
BIOCON.NS,income,2022-03-31 00:00:00,EBIT,10507000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Net Interest Income,445000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Interest Expense,676000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Interest Income,1121000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Normalized Income,7260880000.0
BIOCON.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,6484000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Total Expenses,69569000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,38000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Diluted Average Shares,1196351671.0
BIOCON.NS,income,2022-03-31 00:00:00,Basic Average Shares,1191074681.0
BIOCON.NS,income,2022-03-31 00:00:00,Diluted EPS,5.42
BIOCON.NS,income,2022-03-31 00:00:00,Basic EPS,5.44
BIOCON.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,6484000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,6484000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
BIOCON.NS,income,2022-03-31 00:00:00,Net Income,6484000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Minority Interests,-1232000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,7716000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Net Income Discontinuous Operations,
BIOCON.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,7716000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Tax Provision,2115000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Pretax Income,9831000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,1193000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Special Income Charges,-843000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Other Special Charges,835000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Write Off,8000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,445000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,676000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,1121000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Operating Income,10679000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Operating Expense,42333000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Other Operating Expenses,9399000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,8142000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Amortization,1310000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,6832000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Research And Development,3105000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Selling General And Administration,4307000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,2438000000.0
BIOCON.NS,income,2022-03-31 00:00:00,General And Administrative Expense,1869000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,38000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Gross Profit,53012000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Cost Of Revenue,27236000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Total Revenue,80248000000.0
BIOCON.NS,income,2022-03-31 00:00:00,Operating Revenue,80248000000.0
BIOCON.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
BIOCON.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
BIOCON.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
BIOCON.NS,income,2021-03-31 00:00:00,Total Unusual Items,
BIOCON.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
BIOCON.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
BIOCON.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
BIOCON.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
BIOCON.NS,income,2021-03-31 00:00:00,EBITDA,
BIOCON.NS,income,2021-03-31 00:00:00,EBIT,
BIOCON.NS,income,2021-03-31 00:00:00,Net Interest Income,
BIOCON.NS,income,2021-03-31 00:00:00,Interest Expense,
BIOCON.NS,income,2021-03-31 00:00:00,Interest Income,770000000.0
BIOCON.NS,income,2021-03-31 00:00:00,Normalized Income,
BIOCON.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
BIOCON.NS,income,2021-03-31 00:00:00,Total Expenses,
BIOCON.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,58000000.0
BIOCON.NS,income,2021-03-31 00:00:00,Diluted Average Shares,
BIOCON.NS,income,2021-03-31 00:00:00,Basic Average Shares,
BIOCON.NS,income,2021-03-31 00:00:00,Diluted EPS,
BIOCON.NS,income,2021-03-31 00:00:00,Basic EPS,
BIOCON.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
BIOCON.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
BIOCON.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
BIOCON.NS,income,2021-03-31 00:00:00,Net Income,
BIOCON.NS,income,2021-03-31 00:00:00,Minority Interests,
BIOCON.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
BIOCON.NS,income,2021-03-31 00:00:00,Net Income Discontinuous Operations,-97000000.0
BIOCON.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
BIOCON.NS,income,2021-03-31 00:00:00,Tax Provision,
BIOCON.NS,income,2021-03-31 00:00:00,Pretax Income,
BIOCON.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
BIOCON.NS,income,2021-03-31 00:00:00,Special Income Charges,
BIOCON.NS,income,2021-03-31 00:00:00,Other Special Charges,
BIOCON.NS,income,2021-03-31 00:00:00,Write Off,17000000.0
BIOCON.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
BIOCON.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
BIOCON.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,770000000.0
BIOCON.NS,income,2021-03-31 00:00:00,Operating Income,
BIOCON.NS,income,2021-03-31 00:00:00,Operating Expense,
BIOCON.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
BIOCON.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
BIOCON.NS,income,2021-03-31 00:00:00,Amortization,1131000000.0
BIOCON.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
BIOCON.NS,income,2021-03-31 00:00:00,Research And Development,5311000000.0
BIOCON.NS,income,2021-03-31 00:00:00,Selling General And Administration,4888000000.0
BIOCON.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,2359000000.0
BIOCON.NS,income,2021-03-31 00:00:00,General And Administrative Expense,2529000000.0
BIOCON.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,58000000.0
BIOCON.NS,income,2021-03-31 00:00:00,Gross Profit,
BIOCON.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
BIOCON.NS,income,2021-03-31 00:00:00,Total Revenue,
BIOCON.NS,income,2021-03-31 00:00:00,Operating Revenue,
